Redmile Group

Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.

Business Model:

Revenue: $15.9M

Employees: 2-10

Rankings

Detailed Redmile Group Information

Geographic Data

Redmile Group headquarters map

Address: 1 Letterman Dr

City: San Francisco

State: CA

Zip: 94129

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$472M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Redmile Group is a healthcare investment organization that makes venture, growth, and crossover investing across healthcare.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
3/2019 Beam Therapeutics Series B 135M
1/2018 BioNTech Series A 270M
7/2021 Thriveworks Venture Round -
6/2019 Saluda Medical Venture Round 0
4/2011 Oxford Nanopore Technologies Venture Round 41.2M
7/2019 BioNTech Series B 0
12/2013 Invitae Series E 0
11/2013 inui Health Series A 10.5M
3/2021 OncoResponse Series C 0
12/2016 Augmedix Venture Round 23M
10/2021 Science 37 Post-IPO Equity 0
7/2008 PacBio Series E 100M
3/2020 immatics biotechnologies Post-IPO Equity 0
12/2019 Zentalis Pharmaceuticals Series C 85M
9/2017 Call9, Inc. Series B 24M
10/2017 ADC Therapeutics Series E 0
1/2019 Science 37 Series D 0
9/2018 Evox Therapeutics Series B 0
5/2021 HydraFacial Post-IPO Equity 0
10/2015 Audentes Therapeutics Series C 65M
7/2015 Afferent Pharmaceuticals Series C 55M
11/2022 Escient Pharmaceuticals Series C 120M
9/2018 Vapotherm Series D 0
12/2019 ArcherDX Series C 0
4/2015 Jounce Therapeutics Series B 0
1/2021 Genalyte Venture Round 0
5/2019 ElevateBio Series A 150M
6/2017 Nightstar Therapeutics Series C 45M
8/2019 Stereotaxis Post-IPO Equity 25M
1/2021 Impulse Dynamics Series D 60M
8/2017 aTyr Pharma Post-IPO Equity 45M
9/2017 Replimune Group Series B 55M
2/2021 Excision BioTherapeutics Series A -
1/2018 Scholar Rock Series C 47M
4/2023 Orbital Therapeutics Series A 0
6/2021 Strand Therapeutics Series A 52M
6/2022 Scholar Rock Post-IPO Equity 0
9/2018 Atreca Series C 125M
3/2020 ElevateBio Series B 170M
12/2014 Scioderm Series B 20M
10/2015 Gritstone Bio Series A 102M
11/2013 Innate Pharma Post-IPO Equity 27.3M
11/2016 Genalyte Series D 36M
2/2021 Ayala Pharmaceuticals Private Placement 25M
3/2020 Nurix Therapeutics Private Equity Round 120M
2/2014 Aurinia Pharmaceuticals Post-IPO Equity 52M
3/2020 Redx Pharma Post-IPO Equity 33.6M
3/2022 Saluda Medical Equity 125M
9/2018 OncoResponse Series B 40M
2/2021 Evox Therapeutics Series C 96.7M
1/2021 Verve Therapeutics Series B 94M
5/2018 Attenua Series A 35M
9/2019 Repare Therapeutics Series B 82.5M
1/2020 Sonendo Venture Round 85M
5/2017 Xeris Pharmaceuticals Series C 0
9/2022 Ventyx Biosciences Post-IPO Equity 0
2/2019 Hookipa Pharma Series D 37.4M
12/2018 Akero Therapeutics Series B 70M
9/2021 Gritstone Bio Post-IPO Equity 0
1/2019 Cabaletta Bio Series B 0
12/2020 SomaLogic Series A 0
10/2016 Science 37 Series B 31M
12/2017 Allakos Series B 100M
11/2015 First Aid Shot Therapy Series C 24M
9/2021 Attralus Series B 116M
2/2016 Yumanity Therapeutics Series A 51M
8/2022 Kymera Therapeutics Post-IPO Equity 150M
10/2014 MedAvail Series C 0
7/2018 MedAvail Series D 0
7/2019 IGM Biosciences Series C 102M
12/2020 Neuron23 Series B 80M
2/2014 First Aid Shot Therapy Series B 7M
6/2019 ADC Therapeutics Series E 0
10/2019 Augmedix Series B 0
3/2021 Entrada Therapeutics Series B 0
8/2021 Zentera Therapeutics Series B 75M
8/2014 Bellicum Pharmaceuticals Series C 55M
5/2020 Atea Series D 215M
6/2021 Mnemo Therapeutics Series A 90M
1/2016 Syros Pharmaceuticals Series C 40M
9/2021 Lycia Therapeutics Series B 70M
4/2016 Augmedix Venture Round 0
2/2021 Nuvation Bio Post-IPO Equity 502M
6/2020 Shattuck Labs Series B 0
10/2014 Invitae Series F 0
5/2019 AlloVir Series B 120M
2/2019 Neurogene Series A 68.5M
10/2016 True North Therapeutics Series D 45M
3/2020 Amunix Series A 0
6/2012 TriVascular Series D 60M
3/2018 TCR2 Series B 0
9/2020 Escient Pharmaceuticals Series B 77.5M
10/2014 Syros Pharmaceuticals Series B 53M
3/2021 ElevateBio Series C 525M
5/2023 ElevateBio Series D 0
7/2022 AlloVir Post-IPO Equity 0
11/2020 Achilles Therapeutics Series C 69.8M
9/2012 Foundation Medicine Series B 42.5M
3/2017 Virta Health Equity 37M
11/2021 GRO Biosciences Series A 25M
8/2015 Genalyte Series C 0
3/2022 Neuron23 Series C 0
11/2018 Aprea Series C 0
12/2020 Gritstone Bio Post-IPO Equity 125M
12/2020 RayzeBio Series B 105M
9/2019 Achilles Therapeutics Series B 120.9M
3/2020 Kymera Therapeutics Series C 102M
5/2021 Clear Labs Series C 60M
4/2017 Science 37 Series C 35M
4/2014 One Medical Private Equity Round 40M
5/2020 Clear Labs Venture Round 21M
9/2017 Gritstone Bio Series B 93M
8/2020 Science 37 Venture Round 0
9/2020 Lava Therapeutics Series C 83M
5/2017 Vapotherm Series D 0
8/2015 Wave Life Sciences Series B 66M
1/2021 Beam Therapeutics Post-IPO Equity 260M
8/2015 Ovid Therapeutics Series B 75M
7/2021 Prime Medicine Series B 200M
2/2022 Star Therapeutics Venture Round 0
3/2020 Pliant Therapeutics Series C 0
11/2021 The Oncology Institute of Hope and Innovation Post-IPO Equity 275M
6/2015 CytomX Therapeutics Series D 70M
6/2021 RayzeBio Series C 108M
5/2020 CorVent Medical Seed Round 0
11/2013 TriVascular Series E 0
4/2014 Adverum Biotechnologies Series B 55M
3/2021 AgomAb Therapeutics Series B 0
11/2014 Blueprint Medicines Series C 50M
4/2021 Boundless Bio Series B 105M
5/2023 Boundless Bio Series C 0
4/2021 Adagio Therapeutics Series C 0
9/2021 Mammoth Biosciences Series D 0
4/2021 Ceribell Series C 53M
11/2020 Mammoth Biosciences Series C 45M
3/2021 Absci Venture Round 0
10/2021 Sphere Fluidics Venture Round 41.4M
1/2016 Xeris Pharmaceuticals Series C 41M
7/2020 Annexon Biosciences Series C 100M
10/2020 Absci Series E 70M
4/2015 inui Health Series B 35M
1/2018 Alder Biopharmaceuticals Post-IPO Equity 250M
4/2020 Lifesprout Series A 0
6/2017 Deciphera Pharmaceuticals Series C 52M
9/2016 Array BioPharma Post-IPO Equity 1.4M
11/2020 MedAvail Series E 0
5/2022 Rapt Therapeutics PIPE 50M
7/2022 Annexon Biosciences Post-IPO Equity 0
3/2021 Amunix Series B 117M
11/2021 Home Biosciences Seed 15M
6/2018 Gritstone Bio Series C 21M
2/2022 Electra Therapeutics Series B 0
10/2018 Stoke Therapeutics Series B 90M
7/2022 AlloVir Post-IPO Equity 0
7/2022 Annexon Biosciences Post-IPO Equity 0
6/2022 Scholar Rock Post-IPO Equity 0
5/2022 Rapt Therapeutics Post-IPO Equity 0
3/2022 Neuron23 Series C 0
3/2022 Saluda Medical Private Equity Round 0
2/2022 Star Therapeutics Venture Round 0
2/2022 Electra Therapeutics Series B 0
11/2021 The Oncology Institute of Hope and Innovation Post-IPO Equity 0
11/2021 Home Biosciences Seed Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research